Category: Tuberculosis
Europe Tuberculosis
-
2024-2029 Tuberculosis Molecular Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... sale forecasts and supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Tuberculosis tests performed in the following market segments: Hospitals - Commercial/Private ... Read More
-
TB Diagnostic Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 2025-2034. This report on global TB diagnostic market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global TB ... Read More
-
2024 Global Tuberculosis Diagnostics Market: US, Europe, Japan - Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies
... US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Tuberculosis definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the ... Read More
-
Europe Bovine Diagnostics Market Forecast to 2030 – Regional Analysis – by Product [Immunoassay Kits, PCR Reagents & Kits, Hemagglutination Inhibition (HI) Assay, and Other Products], Disease Type [Bovine Viral Diarrhea (BVD), Bovine Tuberculosis (TB), Bovine Mastitis, Foot and Mouth Disease (FMD), and Other Disease Type], and End User (Veterinary Hospitals, Veterinary Clinics, and Other End-Users)
... Bovine Mastitis, Foot and Mouth Disease (FMD), and Other Disease Type], and End User (Veterinary Hospitals, Veterinary Clinics, and Other End-Users) The Europe bovine diagnostics market is expected to grow from US$ 301.31 million in ... Read More
-
Infectious Disease Diagnostics Market, By Technique ( ELISA, Polymerase Chain Reaction (PCR),Immunoassays, Cell Cultures, Others),By Disease Indication (CNS Infection ,Meningitis, Brain Abscess), Diarrheal Disease ( Shigellosis, Cholera, Enteric/Typhoid Fever),Respiratory Infections(Tuberculosis, Influenza, Bronchitis),Blood Infections(Malaria, Dengue, Infectious Mononucleosis, Others),STDs(Chlamydia, Aids, Syphills, Others)),By End User (Hospitals, Diagnostic Centers, Clinics, Government Organizations), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... Mononucleosis, Others),STDs(Chlamydia, Aids, Syphills, Others)),By End User (Hospitals, Diagnostic Centers, Clinics, Government Organizations), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - ... Read More
-
Veterinary Tuberculosis Vaccine Market, by Type (Live Attenuated, Inactivated), by Route of Administration (Sub-cutaneous, Intramuscular, Oral), by Animal Type (Cattle, Dogs, Cats, Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Tuberculosis (TB) is considered a reemerging, infectious granulomatous disease in animals and people caused by acid-fast bacilli of the genus Mycobacterium. Although commonly ... Read More
-
Europe Anti-Infective Agents Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type (Anti-Viral, Anti-Bacterial, Anti-Fungal, and Others), Range (Narrow Spectrum and Broad Spectrum), Route of Administration (IV, Oral, Topical, and Others), Indication (HIV, Tuberculosis, Respiratory Infection, Pneumonia, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, E-Commerce, and Others)
... Indication (HIV, Tuberculosis, Respiratory Infection, Pneumonia, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, E-Commerce, and Others) The Europe anti-infectives agents market is likely to be US$ 41,446.62 million in 2022 and ... Read More
-
Tuberculosis Drugs Market, by Therapy Type (First Line Therapy, and Second Line Therapy), by Disease type (Active TB, and Latent TB), by End User (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and by Region (North America, Latin America, Europe, As
... Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Tuberculosis is a common infectious disease caused by mycobacterium tuberculosis that affects the lungs. The treatment ... Read More
-
2022-2026 Tuberculosis Molecular Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... sale forecasts and supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Tuberculosis tests performed in the following market segments: Hospitals Commercial/Private Labs ... Read More
-
Europe Intradermal Injections Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Method (Normal Sized Needles, Short Needle, and Without Needle), Application (Tuberculin Skin Test, Allergy Test, Local Aesthetics, and Others), End User (Hospitals, Diagnostic Laboratories, Academics and Research Institutes, and Others)
... (Hospitals, Diagnostic Laboratories, Academics and Research Institutes, and Others) The Europe intradermal injections market is expected to reach US$ 2,131.1 million by 2028 from US$ 1,029.4 million in 2021; it is estimated to grow at ... Read More
-
2022-2026 Global Respiratory Disease Testing Market--US, Europe, Japan--Shares and Segment Forecasts--Adenovirus, Coronavirus, Enterovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Rhinovirus, and Tuberculosis
... of the global respiratory disease testing market, including emerging technologies, instrumentation review, volume and sales segment forecasts by country, supplier shares, and strategic profiles of leading competitors. The report is available by section, and can ... Read More
-
2022-2026 France Respiratory Disease Market: Shares and Segment Forecasts-- Adenovirus, Coronavirus, Enterovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Rhinovirus, and Tuberculosis
... market, including emerging technologies, instrumentation review, volume and sales segment forecasts by country, supplier shares, and strategic profiles of leading competitors. About this Report This report presents detailed analysis of the Respiratory Disease market in ... Read More
-
2022-2026 Europe Respiratory Disease Testing Market--France, Germany, Italy, Spain, UK--Shares and Segment Forecasts--Adenovirus, Coronavirus, Enterovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Rhinovirus, and Tuberculosis
... provides analysis of the European respiratory disease testing market, including emerging technologies, instrumentation review, volume and sales segment forecasts by country, supplier shares, and strategic profiles of leading competitors. The report is available by section, ... Read More
-
2022-2026 Italy Respiratory Disease Market: Shares and Segment Forecasts-- Adenovirus, Coronavirus, Enterovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Rhinovirus, and Tuberculosis
... market, including emerging technologies, instrumentation review, volume and sales segment forecasts by country, supplier shares, and strategic profiles of leading competitors. About this Report This report presents detailed analysis of the Respiratory Disease market in ... Read More
-
2022-2026 Germany Respiratory Disease Market: Shares and Segment Forecasts-- Adenovirus, Coronavirus, Enterovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Rhinovirus, and Tuberculosis
... market, including emerging technologies, instrumentation review, volume and sales segment forecasts by country, supplier shares, and strategic profiles of leading competitors. About this Report This report presents detailed analysis of the Respiratory Disease market in ... Read More
-
2022-2026 UK Respiratory Disease Market: Shares and Segment Forecasts-- Adenovirus, Coronavirus, Enterovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Rhinovirus, and Tuberculosis
... market, including emerging technologies, instrumentation review, volume and sales segment forecasts by country, supplier shares, and strategic profiles of leading competitors. About this Report This report presents detailed analysis of the Respiratory Disease market in ... Read More
Research Assistance
